Today in News History

On July 13, several notable moments in the history of News stand out. In 1628, Robert Shirley, English soldier and diplomat (born 1581) passed away. In 1789, Victor de Riqueti, marquis de Mirabeau, French economist and academic (born 1715) passed away. In 1814, The Carabinieri, the national gendarmerie of Italy, is established. In 1957, Cameron Crowe, American director, producer, and screenwriter was born. In 1973, Watergate scandal: Alexander Butterfield reveals the existence of a secret Oval Office taping system to investigators for the Senate Watergate Committee. In 1995, Space Shuttle Discovery is launched on STS-70 to deploy the TDRS-7 satellite. In 2003, French DGSE personnel abort an operation to rescue Íngrid Betancourt from FARC rebels in Colombia, causing a political scandal when details are leaked to the press. In 2014, Lorin Maazel, French-American violinist, composer, and conductor (born 1930) passed away. In 2017, Liu Xiaobo, Chinese literary critic, human rights activist (born 1955) passed away. In 2024, Thomas Matthew Crooks, American student, known for attempting to assassinate former US President Donald Trump (born 2003) passed away. Together, these milestones provide historical context for today's news news and ongoing narratives.

[Best Brand] Miracell secures FDA 510(k) clearance for stem cell processing system

The korea Herald News

The korea Herald News

·

June 24, 2026

·

center
[Best Brand] Miracell secures FDA 510(k) clearance for stem cell processing system

STEM CELL PROCESSING SYSTEM MIRACELL SMART M-CELL Stem cell technology firm Miracell has secured US Food and Drug Administration 510(k) clearance for its integrated cell-processing system, marking a significant milestone in the company's efforts to expand its presence in the global regenerative medicine market. The FDA granted 510(k) clearance in April for a system comprising the Smart M-Cell cell concentration device, the BSC blood kit and the BmSC bone marrow kit. The clearance followed a subs

Narrative Intelligence Brief

This article was published by The korea Herald News, a source frequently categorized with a center bias based in South Korea. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of The korea Herald News, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.

Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.

How other outlets are covering this story

Compare narratives across 25 related reports from 25 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.

Coverage bias distribution

25 sources

Left 28%

Center 44%

Right 16%


The korea Herald News

center

· Jun 24, 2026

[Best Brand] Miracell wins FDA clearance for stem cell processing system

STEM CELL PROCESSING SYSTEM MIRACELL SMART M-CELL Stem cell technology firm Miracell has secured clearance from the US Food and Drug Administration for its integrated cell-processing system, marking a significant milestone in the company's efforts to expand its presence in the global regenerative medicine market. The FDA approved the system comprising the Smart M-Cell cell concentration device, the BSC blood kit and the BmSC bone marrow kit in April. This FDA clearance comes as Smart M-Cell demo

Korea Times News

lean left

· Jul 1, 2026

Celltrion secures FDA’s 1st interchangeable status for Rituximab biosimilar

Celltrion secures FDA’s 1st interchangeable status for Rituximab biosimilar

The Eastern Herald

center

· Jul 5, 2026

FDA Clears a Transplant Therapy Built to Cut Chronic GVHD From 44% to 13%

The FDA approved Tregzi, Orca Bio's engineered cell therapy, after a 187-patient trial found it cut moderate-to-severe chronic graft-versus-host disease from 44 with standard transplants to 13. The tradeoff patients now face is a newer therapy without years of follow-up data behind it.

The West Australian

lean right

· Jul 13, 2026

Record revenue for Orthocell as collagen products sales rise and international rollout advances

Regenerative medicine manufacturer Orthocell has booked its best revenue results on the back of rising adoption of its flagship product, a collagen wrap used in nerve repair.

CNBC

lean left

· Jun 29, 2026

Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities

Eli Lilly and Regeneron are among the first seven companies the FDA has selected for its PreCheck Pilot Program, CNBC has learned.

CNET

center

· Jul 10, 2026

The Best Whitening Toothpastes Dentists Recommend to Their Patients

For removing stains and keeping your pearly whites bright, these are the best dentist-approved whitening toothpastes.

Investing.com

center

· Jun 29, 2026

Form 4 Celldex Therapeutics Inc For: 29 June

Form 4 Celldex Therapeutics Inc For: 29 June

Jewish News Syndicate

center

· Jun 29, 2026

Treatment may spare children repeated surgeries for vascular defects

The newly introduced procedure allows medication to penetrate the malformation’s cells at concentrations up to 10,000 times greater than in conventional treatment.

The Hindu BusinessLine

lean right

· Jun 26, 2026

Alembic Pharma gets USFDA final approval for Oseltamivir oral suspension

The approved ANDA is therapeutically equivalent to the reference listed drug (RLD), Tamiflu Oral Suspension, 6 mg/mL, of Hoffmann-La Roche Inc

Bon Appétit

center

· Jul 7, 2026

The Best Wine Glasses for Everyday Drinking and Special Occasion Bottles (2026)

From everyday universals to beautiful crystal for your fanciest pours, here’s the stemware you need—and the stemware you don’t.

The Motley Fool

lean left

· Jul 10, 2026

Here's Why Shares in Novo Nordisk Rival, Agios Pharmaceutical, Soared This Week

An accelerated approval for Agios' key drug to treat sickle cell disease appears to be on the cards.

Seeking Alpha

lean right

· Jun 26, 2026

Precigen: Entering The Oncology 'Sweet Spot'

Precigen: Entering The Oncology 'Sweet Spot'

ZDNet

center

· Jun 27, 2026

The E Ink tablet that successfully replaced my iPad and Kindle is still 30% off on Amazon right now

If you're in the market for a tablet, you literally need look no further than the TCL Nxtpaper 11 Plus, especially at this price.

Sydney Morning Herald

lean left

· Jun 30, 2026

Amplia reshapes board for next phase of cancer drug push

Amplia Therapeutics has handed the chairman’s role to Jane Bell AM as pancreatic cancer trial results and US regulatory progress prepare it for the next phase of drug development.

Gizmodo

left

· Jun 22, 2026

Say Hello to the New Species of Fly Officially Approved to Clean Human Wounds

The FDA has cleared Lucilia cuprina larvae for use in maggot debridement therapy.

BERNAMA

center

· Jul 8, 2026

Business : Vivani, Novo Nordisk Sign Agreement To Evaluate Weight Management Implant

KUALA LUMPUR, July 8 (Bernama) -- Vivani Medical Inc (Vivani), a biopharmaceutical company developing ultra long-acting drug implants, has signed an agreement with Novo Nordisk to evaluate its semaglutide drug implant, NPM-139, for chronic weight management.

The Hill

center

· Jul 8, 2026

Gene therapy for children with sickle cell disease approved by FDA

A new treatment for children aged 2 or older with sickle cell disease has been approved by the U.S. Food Drug Administration.

L.A. Times - Health

left

· Jun 30, 2026

Contributor: Mental health care isn't ready for psychedelic side effects

Accelerated FDA approval will invite recklessness. But don't block these important medications. Take steps to prepare.

Global News

center

· Jun 30, 2026

Canada approves 1st generic semaglutide shot for weight loss

It's the third generic semaglutide product approved by the department, though the first two were authorized for the treatment of Type 2 diabetes in adults.

NDTV

lean right

· Jul 3, 2026

Rs 85,000 In US Vs Rs 35 In India: Woman's Outrage Over Cancer Drug Prices Goes Viral

The viral Instagram video claims a cancer medicine that costs about Rs 85,000 per pill in the US is available in India for as little as Rs 35 in generic form.

MakeUseOf

Unknown

· Jul 10, 2026

My Galaxy answers spam calls for me now, and the transcripts are gold

Let your phone handle calls for you.

Mashable

lean left

· Jul 3, 2026

The best budget tablets of 2026: Testing Apple, Lenovo, and Amazon Fire tablets

Want a tablet but don't want to break the bank? We tested affordable tablets to find the best options from Amazon, Lenovo, and Apple.

Digital Trends

Unknown

· Jun 25, 2026

Xiaomi 17T Pro review: Not quite Ultra, but I didn’t want to put it down

Xiaomi’s latest T-series Pro phone delivers Leica-tuned cameras, excellent battery life, strong gaming performance, and a polished design, though its size and software quirks may not be for everyone.

ScienceDaily

Unknown

· Jul 8, 2026

New weight loss pill beats oral Ozempic in major trial

A new once-daily weight-loss pill called orforglipron delivered better weight loss and blood sugar improvements than the leading oral semaglutide in a major clinical trial. The tablet could offer a more convenient alternative to injectable drugs like Ozempic and Wegovy because it doesn't require refrigeration or special timing with meals. It's also cheaper to manufacture, which could expand access globally.

Inc.com

center

· Jul 7, 2026

Tom’s of Maine Marketed Itself as a Natural Alternative. Now It Owes $2.9 Million Over Alleged Bacteria-Tainted Water

A federal inspection found mold-like substances and bacteria at the plant behind the “natural” toothpaste brand.

Topics:

World · 6
Politics · 5
Technology · 5
Business · 5
Entertainment · 2

Related coverage for "[Best Brand] Miracell secures FDA 510(k) clearance for stem cell processing system": The korea Herald News — [Best Brand] Miracell wins FDA clearance for stem cell processing system. Korea Times News — Celltrion secures FDA’s 1st interchangeable status for Rituximab biosimilar. The Eastern Herald — FDA Clears a Transplant Therapy Built to Cut Chronic GVHD From 44% to 13%. The West Australian — Record revenue for Orthocell as collagen products sales rise and international rollout advances. CNBC — Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities. CNET — The Best Whitening Toothpastes Dentists Recommend to Their Patients. Investing.com — Form 4 Celldex Therapeutics Inc For: 29 June. Jewish News Syndicate — Treatment may spare children repeated surgeries for vascular defects. The Hindu BusinessLine — Alembic Pharma gets USFDA final approval for Oseltamivir oral suspension. Bon Appétit — The Best Wine Glasses for Everyday Drinking and Special Occasion Bottles (2026). The Motley Fool — Here's Why Shares in Novo Nordisk Rival, Agios Pharmaceutical, Soared This Week. Seeking Alpha — Precigen: Entering The Oncology 'Sweet Spot'. ZDNet — The E Ink tablet that successfully replaced my iPad and Kindle is still 30% off on Amazon right now. Sydney Morning Herald — Amplia reshapes board for next phase of cancer drug push. Gizmodo — Say Hello to the New Species of Fly Officially Approved to Clean Human Wounds. BERNAMA — Business : Vivani, Novo Nordisk Sign Agreement To Evaluate Weight Management Implant. The Hill — Gene therapy for children with sickle cell disease approved by FDA. L.A. Times - Health — Contributor: Mental health care isn't ready for psychedelic side effects. Global News — Canada approves 1st generic semaglutide shot for weight loss. NDTV — Rs 85,000 In US Vs Rs 35 In India: Woman's Outrage Over Cancer Drug Prices Goes Viral. MakeUseOf — My Galaxy answers spam calls for me now, and the transcripts are gold. Mashable — The best budget tablets of 2026: Testing Apple, Lenovo, and Amazon Fire tablets. Digital Trends — Xiaomi 17T Pro review: Not quite Ultra, but I didn’t want to put it down. ScienceDaily — New weight loss pill beats oral Ozempic in major trial. Inc.com — Tom’s of Maine Marketed Itself as a Natural Alternative. Now It Owes $2.9 Million Over Alleged Bacteria-Tainted Water